The combined use of recombinant human epidermal growth factor (rh-EGF, Nepidermin) and fractional carbon dioxide laser in reducing cutaneous scar formation

Ben-Nakhi M, Park EJ, Hong JP.

The combined use of recombinant human epidermal growth factor (rh-EGF, Nepidermin) and fractional carbon dioxide laser in reducing cutaneous scar formation.

Journal of wound technology 2012; (15).

wound5

Topical use of recombinant human epidermal growth factor (EGF)-based cream to prevent radiation dermatitis in breast cancer patients: a single-blind randomized preliminary study

The prediction and prevention of laser-induced post-inflammatory hyperpigmentation

R & D